Browse the evidence

Substituting red meat or dairy products for carbohydrate-dense foods is associated with a significantly increased risk of coronary heart disease (CHD) mortality in postmenopausal women.

Avoid replacing carbohydrates with red meat or dairy if you want to protect your heart. This study found that doing so increases the risk of dying from heart disease by 41-44%. Instead, if you are reducing carbs, choose vegetable protein sources like legumes, nuts, and tofu, which were associated with a 30% lower risk of heart disease mortality.

In obesity, elevated saturated fatty acids and proinflammatory cytokines activate JNK and IKK kinases, which phosphorylate insulin receptor substrate (IRS) on inhibitory serine residues, thereby blocking PI3K/Akt signaling and causing insulin resistance.

If you have excess body fat, your cells are likely resisting insulin due to inflammatory signaling triggered by fats and cytokines. This isn't permanent damage; it's a reversible signaling block. Reducing caloric excess and saturated fat intake can lower the metabolic stress that triggers this inflammatory kinase activity, potentially restoring insulin sensitivity.

Roux-en-Y gastric bypass (RYGBP) accelerates exogenous glucose appearance and enhances postprandial GLP-1 and PYY secretion compared to gastric banding (GB) and controls, leading to earlier and higher insulin peaks and faster glucose clearance.

For individuals undergoing Roux-en-Y gastric bypass, the procedure triggers a rapid release of gut hormones (GLP-1, PYY) and faster glucose absorption, which leads to a stronger and earlier insulin response. This hormonal shift helps clear glucose from the blood faster than in non-surgical individuals or those with gastric banding, contributing to improved glucose control even before significant weight loss occurs.

Gastric bypass (RYGBP) leads to enhanced postprandial suppression of ghrelin and increased PYY secretion compared to gastric banding and controls, which may contribute to reduced food intake.

Roux-en-Y gastric bypass increases the secretion of PYY and enhances the suppression of ghrelin after eating. These hormonal changes are associated with reduced food intake and may help patients feel fuller sooner and eat less compared to those who undergo gastric banding or no surgery.

The higher n-3 PUFA content in organic meat is primarily caused by the high grazing/forage-based diets required by organic farming standards.

The nutritional advantage of organic meat comes from the animals' diet. Organic standards require more forage and grazing, which naturally increases the healthy fats in the meat. This is a direct result of the farming method, not just a labeling difference.

Organic meat does not have significantly different concentrations of saturated fatty acids (SFA) or monounsaturated fatty acids (MUFA) compared to conventional meat.

You should not expect organic meat to have less saturated fat than conventional meat. The main nutritional difference is in the healthy unsaturated fats (n-3), not the saturated fats.

Obesity is associated with 'leptin resistance,' where high circulating levels of leptin fail to produce expected anorexigenic effects due to receptor over-stimulation and impaired transport across the blood-brain barrier.

In obesity, your body produces plenty of the satiety hormone leptin, but your brain stops listening to it (leptin resistance). Simply having high leptin doesn't help you lose weight. Future treatments aim to bypass this resistance rather than just adding more hormone.

Gut hormones including GLP-1, PYY, and OXM are anorexigenic (appetite-suppressing) and are released in higher amounts after GI surgery, contributing to weight loss, whereas Ghrelin (orexigenic) levels are often reduced.

Your gut releases hormones like GLP-1 and PYY that tell your brain you are full. GI surgery works by boosting these hormones. New medications mimic this effect to help you lose weight without surgery.

Ectopic fat accumulation in visceral, hepatic, and pericardial depots acts as an active endocrine organ that promotes cardiovascular disease through insulin resistance, systemic inflammation, and oxidative stress, independent of overall body mass index.

Your weight on the scale is less important than where your fat is stored. Even if you are lean, excess fat around your organs (liver, heart, abdomen) can drive heart disease risk through inflammation and insulin resistance. Focus on metabolic health markers rather than just BMI.

Nonalcoholic fatty liver disease (NAFLD) is an independent predictor of incident cardiovascular events, driven by hepatic insulin resistance and systemic inflammation.

Fatty liver is not just a liver problem; it significantly increases your risk of heart disease and stroke, independent of your weight. Managing liver fat is crucial for cardiovascular health.

Dysregulation of homeostatic signals (specifically insulin resistance in the VTA) disrupts the inhibition of dopamine neurons, leading to unchecked motivation for food cues and contributing to obesity.

If you struggle with overeating despite being full, it may not be a failure of willpower but a biological signal failure. High insulin levels can block the brain's 'stop' signal for food rewards. Managing insulin sensitivity through diet and exercise may help restore the brain's ability to ignore food cues when not hungry.

Short-term exposure to palatable food can permanently alter brain wiring (synaptic density) to increase future food seeking, a process that can be reversed by insulin signaling.

Eating highly palatable food can 'prime' your brain to want more for days. However, this effect is reversible. Maintaining metabolic health and insulin sensitivity can help 'unwire' these cravings, preventing a single indulgence from triggering a binge cycle.

Obesity is associated with reduced striatal D2 receptor availability, which may drive compulsive food seeking and resistance to punishment, creating a feedback loop of overeating.

Obesity often involves a biological reduction in dopamine receptors, making food rewards feel less satisfying and requiring more food to feel good. This is a biological adaptation, not just a character flaw. Reducing exposure to hyper-palatable foods can help reset receptor sensitivity over time.

NOX2-derived cytosolic ROS production is required for exercise-stimulated glucose uptake and GLUT4 translocation in skeletal muscle.

During moderate-intensity exercise, your body produces specific reactive oxygen species (ROS) via the NOX2 enzyme to signal muscles to take up glucose. This is a necessary signaling event, not just damage. While you don't need to 'increase' ROS intentionally, understanding that some oxidative stress is functional helps explain why extreme antioxidant supplementation might interfere with metabolic adaptations to exercise.

Visual normalization theory posits that increased population exposure to larger body sizes recalibrates internal visual norms, raising the threshold for what is perceived as 'overweight' and causing widespread under-detection of adiposity in self, children, and others.

If you or your family consistently fail to recognize that you are overweight despite objective measures, it may be due to 'visual normalization'—your brain has adapted to larger body sizes as the new normal. To counter this, rely on objective metrics (BMI, waist circumference) rather than visual estimation alone, and be aware that recognizing your status might trigger psychological stress, so seek supportive, non-stigmatizing health resources.

In humans with extreme BMI (obesity or anorexia), circulating irisin levels are primarily determined by fat mass rather than daily physical activity or resting energy expenditure.

If you have obesity, your body is already producing high levels of irisin, likely as a response to the high fat mass. This does not mean exercise is useless, but it suggests that simply exercising more may not linearly increase irisin or metabolic benefits in the same way it might in lean individuals. The hormonal environment is already saturated by the presence of adipose tissue.

Cold exposure and beta-3 adrenergic agonists are primary physiological and pharmacological agents that induce the browning of white adipose tissue.

Exposing your body to cold temperatures (like cold showers or cool rooms) stimulates your sympathetic nervous system, which can trigger white fat to turn into energy-burning beige fat. Pharmacological beta-3 agonists do this too, but lifestyle cold exposure is the natural, side-effect-free method.

Insulin regulates adipose tissue development and function by activating specific insulin receptor (INSR) splice variants (INSR-A and INSR-B) and downstream signaling cascades (PI3K/AKT), which control glucose uptake, lipid storage, and adipokine secretion.

Understand that insulin is essential for healthy fat tissue function, including cell survival and the release of beneficial hormones. The goal is not to eliminate insulin, but to maintain sensitivity so it can perform these critical roles without causing metabolic dysfunction.

Visceral adipose tissue (VAT) exhibits higher rates of insulin-stimulated glucose uptake and more rapid insulin signaling activation compared to subcutaneous adipose tissue (SAT), which may contribute to its distinct metabolic impact.

Not all fat is the same. Visceral fat (around organs) is more metabolically active and responsive to insulin than subcutaneous fat (under the skin), which may explain why visceral fat accumulation is more strongly linked to metabolic risks.

Insulin negatively regulates the secretion of resistin and omentin, while positively regulating the secretion of adiponectin, leptin, and other adipokines, thereby influencing systemic insulin sensitivity and energy balance.

Insulin influences the hormones your fat cells release. It boosts beneficial hormones like adiponectin (which improves insulin sensitivity) and leptin (which regulates appetite), while suppressing others like resistin. This complex interplay helps maintain metabolic balance.

Continuous administration of fat-free, eucaloric diets (via intravenous or nasogastric routes) induces biochemical essential fatty acid (EFA) deficiency in healthy adult humans within 2 weeks, characterized by decreased linoleic acid and appearance of eicosatrienoic acid in plasma lipids.

If you are receiving intravenous nutrition or a strictly fat-free diet for an extended period, you are at high risk for essential fatty acid deficiency. Medical protocols should include periodic fat emulsions or intermittent feeding to mobilize body stores and prevent biochemical deficiency, even if clinical symptoms like dermatitis are not immediately visible.

Metabolic switching (the dynamic capacity of skeletal muscle to switch between fat and carbohydrate oxidation) is an intrinsic property of skeletal muscle cells, independent of neuroendocrine influences, and mirrors the donor's in vivo insulin sensitivity and metabolic flexibility.

Your body's ability to switch between burning fat and carbs is largely determined by your muscle cells' intrinsic properties, which are linked to your genetic makeup and past metabolic history. This means that 'metabolic flexibility' isn't just about what you eat today, but how your muscle cells are wired. If you struggle with fat oxidation, it may be an intrinsic cellular trait rather than just a lack of willpower, suggesting that personalized approaches based on metabolic phenotype may be more effective than generic advice.

Dietary fiber promotes the production of beneficial tryptophan metabolites, specifically indolelactic acid (ILA) and indolepropionic acid (IPA), by making more tryptophan available for Stickland fermentation.

To support gut health and potentially reduce the production of harmful metabolites like indole, incorporate fermentable fibers (such as pectin found in apples) into your diet. This encourages beneficial bacteria to produce protective metabolites (ILA, IPA) and suppresses the production of indole, which is linked to chronic kidney disease risk.

Delayed and accelerated aging share common longevity assurance mechanisms, specifically the suppression of the GH/IGF1 axis and oxidative metabolism coupled with upregulated stress responses.

Longevity may be linked to a biological shift away from growth (specifically GH/IGF1 signaling) toward cellular repair and stress resistance. While you cannot directly 'dose' this hormonal axis safely, interventions like calorie restriction mimic this state, suggesting that managing growth-promoting signals might be key to healthspan.